Bio Special Premium Article
Testing and Tenacity During the Pandemic : Attilio Focarete
Now, more than a year has passed since Attilio Focarete, Managing Director for Italy, Spain and Portugal at PerkinElmer, who, with his teams, witnessed thi...
July 09, 2021 | Opinion
Cell and Gene Therapy: A Multifaceted Approach
The active research in these areas not only encompasses laboratory bench work and imaging; it increasingly involves advanced computational methods in image...
July 02, 2021 | Opinion
Best practices for a successful bioprocess technology transfer
What is tech transfer, and when does it happen? Technology transfer is a formalized process for moving the manufacture of a drug from one facility, one sc...
June 14, 2021 | Analysis
The Cost of Under- and Over-Coating Zinc
But for manufacturers who provide these zinc-coated products, the cost of zinc has increased substantially over the past few years, emphasizing the need to...
May 26, 2021 | Opinion | By By Chris Burnett
Most Read
- How Innovation Gaps in Biopharma Raise New Safety Concerns
- Smart Implants and the Future of Musculoskeletal Injury Treatment
- How Ethical Gaps in Psychiatry Could Undermine Biopharma Progress
- The Evolving Landscape of Women’s Health Innovation in the Asia-Pacific
- Using NLP-Driven Decision Support in Emergency Health Assistance
- Taiwan Steps Into the Global Spotlight With a New Cancer Therapy
- The Role of Unique Device Identification (UDI) in Tracing Medical Device Safety
- The Importance of a Patient’s Mental Health During Clinical Trials
Bio Jobs
- Avantor’s New CEO Ligner Aims to Unlock Global Potential and Deliver Shareholder Value
- AstraZeneca Commits $50 Billion to U.S. Expansion by 2030 in Biggest-Ever Global Investment
- Thermo Fisher, SAMRC, and South Africa’s Department of Science and Innovation Launch CATIR to Nurture Next-Gen Scientists
- Cube Biotech Appoints Former Sartorius CEO Dr. Joachim Kreuzburg to Board of Directors
- FDA’s AI Transition Marks a Turning Point in Drug Review: Industry Faces Pressure to Adapt Amid 20% Workforce Cut
- WuXi XDC Completes Mechanical Build of Singapore Bioconjugate Manufacturing Hub
News
Editor Picks
